Lilla Horvath M.D.

Lilla Horvath MD is a highly experienced professional in the pharmaceutical and medical fields, currently serving as Senior Director of Product Development at Jazz Pharmaceuticals since December 2021. Prior roles include Director of Portfolio & Translational Strategy and Associate Director of Development Operations at GW Pharmaceuticals plc from July 2017 to July 2022, along with experience as a Medical Science Liaison at both GW Pharmaceuticals and Sanofi Genzyme. Earlier in their career, Lilla worked at Columbia University Department of Psychiatry and NYU Langone Medical Center as a Postdoctoral Fellow, contributing to significant research on genetic risks for bipolar illness and epilepsy-related studies. Lilla earned a Doctor of Medicine (M.D.) in Neuroscience from Semmelweis University School of Medicine in Hungary and obtained the USMLE - ECFMG Certificate between 2012 and 2014.